
Peter I Karachunski MD
Associate Professor, Pediatric neurology University of Minnesota Medical School
Join to view full profile
420 Delaware Street SeMoos tower 13-240 MMC 295Minneapolis, MN 55455
Phone+1 612-626-2499
Fax+1 612-273-0886
Dr. Karachunski is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of MinnesotaFellowship, Child Neurology, 2002 - 2005
University of MinnesotaResidency, Pediatrics, 2000 - 2003
Russian State Medical UniversityClass of 1987
Certifications & Licensure
MN State Medical License 2005 - 2027
American Board of Psychiatry and Neurology Neurology with Special Qualification in Child Neurology
American Board of Psychiatry and Neurology Neuromuscular Medicine
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2012, 2014-2017
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2012, 2014-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
Publications & Presentations
PubMed
- L-Cysteine and N-Acetylcysteine Supplementation Improves Clinical Outcome in a Patient With COXPD10.Nishitha R Pillai, Sara A Elsbecker, Grace Bronken McCarthy, Kaitlin Weisshappel, Peter Karachunski
American Journal of Medical Genetics. Part A. 2026-09-17 - 2 citationsConfirmatory long-term efficacy and safety results of ataluren in patients with nmDMD from Study 041, an international, randomized, double-blind, placebo-controlled, P...Dmitry Vlodavets, Shiwen Wu, Anna Kostera-Pruszczyk, Jong-Hee Chae, Sheffali Gulati
Journal of Comparative Effectiveness Research. 2025-10-01 - 3 citationsReduction of Preexisting AAV9 Antibody Titers Before Onasemnogene Abeparvovec Administration in Twins With Spinal Muscular Atrophy.Ryan W Nelson, Cody A Cox, Molly Stark, Andrew D Johnson, Kelly Sichmeller
Neurology. 2025-08-26
Journal Articles
- TANGO2: Expanding the Clinical Phenotype and Spectrum of Pathogenic VariantsJennifer N Dines, Heather C Mefford, Barbara Burton, Joline Dalton, Alice Basinger, Peter Karachunski, Can Ficicioglu, Katherine L Helbig, Nature
Press Mentions
Safety, Tolerability, and Efficacy of Viltolarsen in Boys with Duchenne Muscular Dystrophy Amenable to Exon 53 SkippingMay 26th, 2020
Toddler Who Got World’s Most Expensive Drug WalksFebruary 25th, 2020
Toddler with Fatal Muscle Condition ‘Recovers’ After $2m Infusion of World’s Most Expensive DrugFebruary 25th, 2020
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: